On the Use of Propensity Score Matching in Biomedicine and Pulmonology

Maturo, Fabrizio; Rambaud, Salvador Cruz

doi:10.1016/j.arbres.2021.12.010

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Propensity score matching (PSM) can eliminate the inherent indication bias caused by observational nonrandom data and more accurately assess the impact of treatment on outcomes, resulting in its increasing application in clinical research. 8,9 We conducted a retrospective comparative analysis of the therapeutic effects and symptom improvements of UAE and LM for uterine broids based on the PSM method, aiming to determine which treatment method is more bene cial for patients.…”

Section: Introductionmentioning

confidence: 99%

Comparative Efficacy of Uterine Artery Embolization versus Laparoscopic Myomectomy in Treating Uterine Fibroids: A Propensity Score Matched Analysis

Wei,

Sun,

et al. 2024

Preprint

View full text Add to dashboard Cite

Objective: The aim of this study was to comparatively analyze the therapeutic effects of uterine artery embolization (UAE) and laparoscopic myomectomy (LM) on uterine fibroids to determine which treatment method is more beneficial for patients. Materials and Methods:A retrospective study was conducted on 396 patients who underwent UAE(n=153)or LM (n=243)treatment from April 2010 to September 2019. After 1:1 propensity score matching(PSM), a comparative analysis was conducted on surgical trauma magnitude, postoperative recovery time, improvement in associated symptoms and quality of life, surgical adverse events, recurrence rates, and further interventions. Results: In PSM, 66 pairs (132 patients) were successfully matched. Both treatments significantly alleviated symptoms and enhanced quality of life. Compared to the LM group, the UAE group had less intraoperative bleeding (P<0.001), a lower rate of hemoglobin decrease (P<0.001), shorter operation, postoperative, and overall hospital stays (P<0.001), and a lower postoperative recurrence rate (P<0.05), all statistically significant. Moreover, the UAE group showed notable advantages in postoperative activities (P<0.05). However, UAE patients faced higher hospitalization costs (P<0.001). Adverse event rates (7.6% vs. 9.1%) and postoperative reintervention rates (7.6% vs. 7.6%) were relatively low and not significantly different between groups (P>0.05). Conclusion: Both UAE and LM can significantly improve patient symptoms and enhance their quality of life, and both treatment methods have low rates of adverse events and reinterventions. Compared to LM, UAE treatment for uterine fibroids presents advantages such as lesstrauma, faster recovery, and lower recurrence rate,but has higher treatment costs.

show abstract

Section: Introductionmentioning

confidence: 99%